100757-58-2

Usage

Uses

Given the potential biological activity and pharmacological applications of (2Z)-[(4R,5S,6S)-6-(beta-D-glucopyranosyloxy)-5-hydroxy-4-methoxycyclohex-2-en-1-ylidene]ethanenitrile, it can be used in various industries and applications. However, specific uses are not provided in the materials. If further research and development confirm its biological activity or pharmacological properties, it could potentially be used in the following industries:
Used in Pharmaceutical Industry:
(2Z)-[(4R,5S,6S)-6-(beta-D-glucopyranosyloxy)-5-hydroxy-4-methoxycyclohex-2-en-1-ylidene]ethanenitrile could be used as a pharmaceutical compound for [specific medical condition or treatment] due to its potential biological activity and the presence of functional groups common in medicinal chemistry.
Used in Research and Development:
In the scientific community, (2Z)-[(4R,5S,6S)-6-(beta-D-glucopyranosyloxy)-5-hydroxy-4-methoxycyclohex-2-en-1-ylidene]ethanenitrile may serve as a research compound for studying its biological activity, pharmacological properties, and potential interactions with biological targets.

Upstream product

• 352426-54-1 (-)-(1Z)-{(4R,5S,6S)-5-hydroxy-4-methoxy-6-[(2,3,4,6-tetra-O-isobutyryl-β-D-glucopyranosyl)oxy]cyclohex-2-en-1-yliden}acetonitrile 
• 119607-30-6 (+)-2,3,4,6-tetra-O-isobutyryl-α-D-glucopyranosyl bromide 
• 352426-56-3 (-)-(1Z)-{(4R,5R,6S)-5-{[(tert-butyl)dimethylsilyl]oxy}-6-hydroxy-4-methoxycyclohex-2-en-1-yliden}acetonitrile 
• 350809-51-7 (+)-(1E)-{(4R,5R,6S)-5-{[(tert-butyl)dimethylsilyl]oxy}-6-hydroxy-4-methoxycyclohex-2-en-1-yliden}acetonitrile 
• 352426-53-0 (+)-(1E)-{(4R,5S,6S)-5-hydroxy-4-methoxy-6-[(2,3,4,6-tetra-O-isobutyryl-β-D-glucopyranosyl)oxy]cyclohex-2-en-1-yliden}acetonitrile 
• 350809-52-8 (-)-(1E)-{(4R,5S,6S)-5-{[(tert-butyl)dimethylsilyl]oxy}-4-methoxy-6-[(2,3,4,6-tetra-O-isobutyryl-β-D-glucopyranosyl)oxy]cyclohex-2-en-1-yliden}acetonitrile 

Relevant academic research and scientific papers

Total synthesis of (-)-bauhinin

The total synthesis of the naturally occurring cyanoglucoside (-)-bauhinin (1) was achieved starting from the optically pure oxatrinorbornenone 2 in 12 steps and 8% overall yield. The aglycone of (-)-bauhinin was easily obtained from the optically pure oxatrinorbornenone derivative 6 by a Wittig-Horner reaction followed by the opening of the oxa bridge. Glycosidation with tetra-O-isobutyryl-D-glucosyl bromide 9 as the reagent in the Koenigs-Knorr reaction afforded glucoside 10 in 58% yield, which, after photoisomerization and deprotection, gave (-)-bauhinin (1).